RYTM

Rhythm Pharmaceuticals, Inc.

42.67 USD
+0.14 (+0.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Rhythm Pharmaceuticals, Inc. stock is up 17.84% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 May 17:09 19 Jul, 2024 40.00 CALL 275 3315
09 May 16:40 19 Jul, 2024 40.00 CALL 124 2874
13 May 19:35 18 Oct, 2024 50.00 CALL 114 0
22 May 17:35 19 Jul, 2024 40.00 CALL 200 2774
23 May 17:17 19 Jul, 2024 40.00 CALL 512 2671
28 May 18:37 19 Jul, 2024 40.00 CALL 842 2159
29 May 15:47 19 Jul, 2024 35.00 PUT 629 32
29 May 16:32 19 Jul, 2024 35.00 PUT 250 32
29 May 19:02 19 Jul, 2024 35.00 PUT 811 32
21 Jun 16:32 16 Aug, 2024 45.00 CALL 1050 0

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency.